![Jordan Shin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jordan Shin
Technik-/Wissenschafts-/F&E-Leiter bei RENOVACOR, INC.
Profil
Jordan Shin is currently working as the SVP of Clinical Development & Translational Science at Renovacor, Inc. Prior to this, he completed his undergraduate degree from The University of Alabama School of Medicine.
Aktive Positionen von Jordan Shin
Unternehmen | Position | Beginn |
---|---|---|
RENOVACOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jordan Shin
The University of Alabama School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Renovacor, Inc.
![]() Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |